Figure 1. Met and Rsv attenuate preterm birth and dystocia.

(A and B) Treatment schedules for Met and Rsv treatment. (C and D) Percent preterm birth and live pups under Met or Rsv treatment in p53^fl/fl and p53^d/d females. ^‡Three of six p53^d/d females that had preterm birth also showed dystocia. ^§One of ten p53^d/d females showed both preterm birth and dystocia. *P < 0.05, χ² test. (E and F) Percent preterm birth and live pups under Met or Rsv in combination with P₄ 4 hours before an LPS (10 μg) injection in p53^fl/fl and p53^d/d mice. ^‡One of two p53^d/d females that had preterm birth also showed dystocia. ^§One of four p53^d/d females showing preterm birth also had dystocia. *P < 0.05, χ² test.